Shanghai hyamab biotechnology
Webb24 mars 2024 · Shanghai HyaMab Biotech Co.,Ltd. Study record dates These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the … Webb4 juni 2024 · Shanghai HyaMab Biotech Co.,Ltd. ClinicalTrials.gov Identifier: NCT04914351 Other Study ID Numbers: HY-0102-01 : First Posted: June 4, 2024 Key Record Dates: Last …
Shanghai hyamab biotechnology
Did you know?
Webb(71)Applicant: Shanghai Hyamab Biotech Co., Ltd. Shanghai 201203 (CN) (72)Inventors: •DUAN, Qing Shanghai 201210 (CN) •LIU, Lile Shanghai 201210 (CN) •YANG, Dazhi Shanghai 201210 (CN) ng•GiJ AO, Shanghai 201210 (CN) •HU, Lili Shanghai 201210 (CN) •SUI, Ruirui Shanghai 201210 (CN) •WANG, Dongxu Shanghai 201210 (CN) •HAN, Ye ... Webb18 feb. 2024 · HY-0102 in Solid Tumor Drug Details: HY-0102 is under development for the treatment of locally advanced and metastatic solid tumors including head and neck cancer, liver cancer, colorectal cancer, lung cancer. The therapeutic candidate is administered through intravenous route. Report Coverage
Webb27 mars 2024 · 企查查行业:. 企业规模:. 员工人数:. 简介:上海怀越生物科技有限公司成立于2024-03-27,法定代表人为MICHAEL XIN HUI,注册资本为1150万美元,统一社 … Webb6 apr. 2024 · Shanghai HyaMab Biotech Co.,Ltd. Information provided by (Responsible Party): Shanghai HyaMab Biotech Co.,Ltd. Study Details; Tabular View; No Results …
http://simrbio.com/ Webb8 nov. 2024 · Assignee: Shanghai Hyamab Biotech Co., Ltd. Inventors: Heng Pan, Haohan Liu, Yingying Gao, Shaoping Hu, Yong Li, Mingming Pan, Tatchi Teddy Yang, Qing Duan, …
Webb2 sep. 2024 · The latest news, comment and analysis about Shanghai HyaMab Biotechnology from the Vantage editorial team.
Webb17 jan. 2024 · (1) a heavy chain variable region comprising the following three complementary determining regions (CDRs): dating sites for fat womenWebb5 jan. 2024 · Keywords provided by Shanghai HyaMab Biotech Co.,Ltd. HY-0102, solid tumors. Additional relevant MeSH terms: Neoplasms. Study Results No Results Posted … dating sites for dummiesWebb22 mars 2024 · First Received: March 22, 2024 Last Updated: April 5, 2024. Phase: Phase 1 Start Date: March 8, 2024. Overall Status: Active, not recruiting Estimated ... dating sites for early 20sWebb10 maj 2024 · Assignee: Shanghai Hyamab Biotech Co., Ltd. Inventors: Heng Pan, Haohan Liu, Yingying Gao, Shaoping Hu, Yong Li, Mingming Pan, Tatchi Teddy Yang, Qing Duan, Lile Liu Macrocyclic compounds as TRK kinases inhibitors Patent number: 11555042 Abstract: Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods … dating sites for farmers australiaWebbPatent applications and USPTO patent grants for SHANGHAI HYAMAB BIOTECH CO., LTD..The latest application filed is for "nkg2a antibody, preparation method therefor and … dating sites for first respondersWebbSponsors: Lead Sponsor: Shanghai HyaMab Biotech Co.,Ltd. Source: Shanghai HyaMab Biotech Co.,Ltd. Brief Summary: This is a Phase I Clinical Trial to Evaluate the Tolerability, Safety, Pharmacokinetics and Preliminary Antitumor Activity of PE0116 Injection in Treatment of Patients with Advanced Solid Tumor. bj\u0027s in clearwaterWebb15 jan. 2024 · This work was supported by Shanghai ChemPartner Co., Ltd and Shanghai Hyamab Biotechnology Co., Ltd, as a grant from the National Natural Science … dating sites for fishermen